Risk of Primary Gastrointestinal Lymphoma in Patients With Inflammatory Conditions Exposed to Tumor Necrosis Factor Alpha Inhibitors and Immunomodulators: A Case-Control Study (vol 6, otae010, 2024)

被引:0
|
作者
Braga-Neto, Manuel B.
Nasser, Jason
Wang, Xiao Jing
Harmsen, William Scott
Raffals, Laura E.
Camilleri, Michael
Chedid, Victor
机构
关键词
D O I
10.1093/crocol/otae028
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页数:1
相关论文
共 25 条
  • [1] Risk of Primary Gastrointestinal Lymphoma in Patients With Inflammatory Conditions Exposed to Tumor Necrosis Factor Alpha Inhibitors and Immunomodulators: A Case-Control Study
    Braga-Neto, Manuel B.
    Nasser, Jason
    Wang, Xiao Xing
    Harmsen, William Scott
    Raffals, Laura E.
    Camilleri, Michael
    Chedid, Victor
    CROHNS & COLITIS 360, 2024, 6 (01)
  • [2] RISK OF PRIMARY GASTROINTESTINAL LYMPHOMA IN PATIENTS WITH INFLAMMATORY CONDITIONS EXPOSED TO TUMOR NECROSIS FACTOR ALPHA INHIBITORS: A CASE-CONTROL STUDY
    Chedid, Victor G.
    Nasser, Jason
    Wang, Xiao Jing
    Harmsen, William S.
    Raffals, Laura H.
    Camilleri, Michael
    GASTROENTEROLOGY, 2020, 158 (06) : S674 - S675
  • [3] Risk of Non-Hodgkin Lymphoma Following Treatment of Inflammatory Conditions with Tumor Necrosis Factor-Alpha Inhibitors
    Calip, Gregory S.
    Lee, Wan-Ju
    Lee, Todd A.
    Schumock, Glen T.
    Chiu, Brian C-H.
    BLOOD, 2015, 126 (23)
  • [4] Tumor necrosis factor-α polymorphism and risk of primary nephrotic syndrome: A case-control study and meta-analysis
    Zhao, Rongfen
    Wang, Yufeng
    Zhou, Yihua
    Fan, Wu
    Yin, Haiyan
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (06)
  • [5] Evaluation of the Effect of Tumor Necrosis Factor-Alpha Gene Polymorphism on the Risk of Peri-implantitis: A Case-Control Study
    Cury, Patricia R.
    Horewicz, Veronica V.
    Ferrari, Daniel S.
    Brito, Rui, Jr.
    Sendyk, Wilson R.
    Duarte, Poliana M.
    Shibli, Jamil A.
    INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS, 2009, 24 (06) : 1101 - 1105
  • [6] Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study
    Mélanie Gilson
    Laure Gossec
    Xavier Mariette
    Dalenda Gherissi
    Marie-Hélène Guyot
    Jean-Marie Berthelot
    Daniel Wendling
    Christian Michelet
    Pierre Dellamonica
    Florence Tubach
    Maxime Dougados
    Dominique Salmon
    Arthritis Research & Therapy, 12
  • [7] Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study
    Gilson, Melanie
    Gossec, Laure
    Mariette, Xavier
    Gherissi, Dalenda
    Guyot, Marie-Helene
    Berthelot, Jean-Marie
    Wendling, Daniel
    Michelet, Christian
    Dellamonica, Pierre
    Tubach, Florence
    Dougados, Maxime
    Salmon, Dominique
    ARTHRITIS RESEARCH & THERAPY, 2010, 12 (04)
  • [8] Risk of Paradoxical Rheumatoid Arthritis in Inflammatory Bowel Disease Patients Exposed to Tumor Necrosis Factor Inhibitors: A Propensity-Matched Multicenter Study
    Chavan, Akash Keluth
    Jha, Pankhuri
    Perez, Jaime Abraham
    Harper, Elleson
    Sinh, Preetika
    Cooper, Gregory
    Katz, Jeffry
    Cominelli, Fabio
    Regueiro, Miguel
    Mansoor, Emad
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [9] Attenuated adiponectin, omentin, increased interleukin-6 and tumor necrosis factor-alpha levels with altered cognition and depression in non-Hodgkin lymphoma patients: A case-control study
    Kathpalia, Meghavi
    Mishra, Pinki
    Majid, Afsha
    Khan, Mohd. Ashif
    Sharma, Anurag
    Bhurani, Dinesh
    Nidhi
    JOURNAL OF NEUROIMMUNOLOGY, 2024, 392
  • [10] Evaluation the Possible Role of Interleukin-6 and Tumor Necrosis Factor- Alpha in Pathogenesis of Obstructive Sleep Apnea in Obese Patients: A Case-Control Study
    Ahsant, Samaneh
    Fard, Soheil Rahmani
    Riahi, Taghi
    Tinjani, Reyhaneh Taheri
    Mahmoudi, Fatemeh Shamlou
    Alimohamadi, Yousef
    Kooranifar, Siavash
    Hosseinipour, Ali
    Minaeian, Sara
    GALEN MEDICAL JOURNAL, 2022, 11